Global Age-Related Macular Degeneration (AMD) AI Screening System Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Age-related macular degeneration (AMD) represents one of leading cause of visual impairment in developed countries and a major target for AI-based approaches. The analysis of AMD data is mainly based on optical coherence tomography(OCT) images; thus, image segmentation is a fundamental step for accurately recognizing retinal structures. Many unsupervised AI-based segmentation algorithms have been developed, providing very high performance in detecting retinal features. These algorithms are useful not only for assessing the integrity of retinal structures, but also for localizing and quantifying retinal fluids during follow-up.
The global Age-Related Macular Degeneration (AMD) AI Screening System market size is projected to grow from US$ 83.8 million in 2024 to US$ 3343 million in 2030; it is expected to grow at a CAGR of 84.9% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Age-Related Macular Degeneration (AMD) AI Screening System Industry Forecast” looks at past sales and reviews total world Age-Related Macular Degeneration (AMD) AI Screening System sales in 2022, providing a comprehensive analysis by region and market sector of projected Age-Related Macular Degeneration (AMD) AI Screening System sales for 2023 through 2029. With Age-Related Macular Degeneration (AMD) AI Screening System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Age-Related Macular Degeneration (AMD) AI Screening System industry.
This Insight Report provides a comprehensive analysis of the global Age-Related Macular Degeneration (AMD) AI Screening System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Age-Related Macular Degeneration (AMD) AI Screening System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Age-Related Macular Degeneration (AMD) AI Screening System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Age-Related Macular Degeneration (AMD) AI Screening System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Age-Related Macular Degeneration (AMD) AI Screening System.
The age-related macular degeneration (AMD) market trends are shaping the growth of the market. For instance rise in the adoption of age-related macular degeneration drugs (AMD) among the geriatric population suffering from age-related macular degeneration (AMD) drives the growth of the age-related macular degeneration (AMD) market size. For instance, according to the 2022 factsheet of World Health Organization, by 2030, 1 in 6 people in the world is projected to be aged 60 years or over, indicating a potential increase in the age-related macular degeneration (AMD) market size.
This report presents a comprehensive overview, market shares, and growth opportunities of Age-Related Macular Degeneration (AMD) AI Screening System market by product type, application, key players and key regions and countries.
Segmentation by Type:
Age-related macular degeneration (AMD) represents one of leading cause of visual impairment in developed countries and a major target for AI-based approaches. The analysis of AMD data is mainly based on optical coherence tomography(OCT) images; thus, image segmentation is a fundamental step for accurately recognizing retinal structures. Many unsupervised AI-based segmentation algorithms have been developed, providing very high performance in detecting retinal features. These algorithms are useful not only for assessing the integrity of retinal structures, but also for localizing and quantifying retinal fluids during follow-up.
The global Age-Related Macular Degeneration (AMD) AI Screening System market size is projected to grow from US$ 83.8 million in 2024 to US$ 3343 million in 2030; it is expected to grow at a CAGR of 84.9% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Age-Related Macular Degeneration (AMD) AI Screening System Industry Forecast” looks at past sales and reviews total world Age-Related Macular Degeneration (AMD) AI Screening System sales in 2022, providing a comprehensive analysis by region and market sector of projected Age-Related Macular Degeneration (AMD) AI Screening System sales for 2023 through 2029. With Age-Related Macular Degeneration (AMD) AI Screening System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Age-Related Macular Degeneration (AMD) AI Screening System industry.
This Insight Report provides a comprehensive analysis of the global Age-Related Macular Degeneration (AMD) AI Screening System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Age-Related Macular Degeneration (AMD) AI Screening System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Age-Related Macular Degeneration (AMD) AI Screening System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Age-Related Macular Degeneration (AMD) AI Screening System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Age-Related Macular Degeneration (AMD) AI Screening System.
The age-related macular degeneration (AMD) market trends are shaping the growth of the market. For instance rise in the adoption of age-related macular degeneration drugs (AMD) among the geriatric population suffering from age-related macular degeneration (AMD) drives the growth of the age-related macular degeneration (AMD) market size. For instance, according to the 2022 factsheet of World Health Organization, by 2030, 1 in 6 people in the world is projected to be aged 60 years or over, indicating a potential increase in the age-related macular degeneration (AMD) market size.
This report presents a comprehensive overview, market shares, and growth opportunities of Age-Related Macular Degeneration (AMD) AI Screening System market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Hardware
- Software
- Medical Institutions
- Great Health Scene
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Hardware
- Software
- Medical Institutions
- Great Health Scene
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Airdoc Technology
- Digital Diagnostics
- Eyenuk
- RetinaLyze System
- Optomed
- Sibionics Technology
- Aeye Health
- VUNO
- Medimaging Integrated Solution
- EyRIS (SELENA+)
- Vistel
- RETINA-AI Health
- Acer Medical
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2019-2030
2.1.2 Age-Related Macular Degeneration (AMD) AI Screening System Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Age-Related Macular Degeneration (AMD) AI Screening System by Country/Region, 2019, 2023 & 2030
2.2 Age-Related Macular Degeneration (AMD) AI Screening System Segment by Type
2.2.1 Hardware
2.2.2 Software
2.3 Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Type
2.3.1 Age-Related Macular Degeneration (AMD) AI Screening System Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Type (2019-2024)
2.4 Age-Related Macular Degeneration (AMD) AI Screening System Segment by Application
2.4.1 Medical Institutions
2.4.2 Great Health Scene
2.5 Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Application
2.5.1 Age-Related Macular Degeneration (AMD) AI Screening System Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Application (2019-2024)
3 AGE-RELATED MACULAR DEGENERATION (AMD) AI SCREENING SYSTEM MARKET SIZE BY PLAYER
3.1 Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Player
3.1.1 Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue by Player (2019-2024)
3.1.2 Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue Market Share by Player (2019-2024)
3.2 Global Age-Related Macular Degeneration (AMD) AI Screening System Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AGE-RELATED MACULAR DEGENERATION (AMD) AI SCREENING SYSTEM BY REGION
4.1 Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Region (2019-2024)
4.2 Global Age-Related Macular Degeneration (AMD) AI Screening System Annual Revenue by Country/Region (2019-2024)
4.3 Americas Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth (2019-2024)
4.4 APAC Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth (2019-2024)
4.5 Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth (2019-2024)
4.6 Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Country (2019-2024)
5.2 Americas Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Type (2019-2024)
5.3 Americas Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Region (2019-2024)
6.2 APAC Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Type (2019-2024)
6.3 APAC Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Country (2019-2024)
7.2 Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Type (2019-2024)
7.3 Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System by Region (2019-2024)
8.2 Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Type (2019-2024)
8.3 Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL AGE-RELATED MACULAR DEGENERATION (AMD) AI SCREENING SYSTEM MARKET FORECAST
10.1 Global Age-Related Macular Degeneration (AMD) AI Screening System Forecast by Region (2025-2030)
10.1.1 Global Age-Related Macular Degeneration (AMD) AI Screening System Forecast by Region (2025-2030)
10.1.2 Americas Age-Related Macular Degeneration (AMD) AI Screening System Forecast
10.1.3 APAC Age-Related Macular Degeneration (AMD) AI Screening System Forecast
10.1.4 Europe Age-Related Macular Degeneration (AMD) AI Screening System Forecast
10.1.5 Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Forecast
10.2 Americas Age-Related Macular Degeneration (AMD) AI Screening System Forecast by Country (2025-2030)
10.2.1 United States Market Age-Related Macular Degeneration (AMD) AI Screening System Forecast
10.2.2 Canada Market Age-Related Macular Degeneration (AMD) AI Screening System Forecast
10.2.3 Mexico Market Age-Related Macular Degeneration (AMD) AI Screening System Forecast
10.2.4 Brazil Market Age-Related Macular Degeneration (AMD) AI Screening System Forecast
10.3 APAC Age-Related Macular Degeneration (AMD) AI Screening System Forecast by Region (2025-2030)
10.3.1 China Age-Related Macular Degeneration (AMD) AI Screening System Market Forecast
10.3.2 Japan Market Age-Related Macular Degeneration (AMD) AI Screening System Forecast
10.3.3 Korea Market Age-Related Macular Degeneration (AMD) AI Screening System Forecast
10.3.4 Southeast Asia Market Age-Related Macular Degeneration (AMD) AI Screening System Forecast
10.3.5 India Market Age-Related Macular Degeneration (AMD) AI Screening System Forecast
10.3.6 Australia Market Age-Related Macular Degeneration (AMD) AI Screening System Forecast
10.4 Europe Age-Related Macular Degeneration (AMD) AI Screening System Forecast by Country (2025-2030)
10.4.1 Germany Market Age-Related Macular Degeneration (AMD) AI Screening System Forecast
10.4.2 France Market Age-Related Macular Degeneration (AMD) AI Screening System Forecast
10.4.3 UK Market Age-Related Macular Degeneration (AMD) AI Screening System Forecast
10.4.4 Italy Market Age-Related Macular Degeneration (AMD) AI Screening System Forecast
10.4.5 Russia Market Age-Related Macular Degeneration (AMD) AI Screening System Forecast
10.5 Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Forecast by Region (2025-2030)
10.5.1 Egypt Market Age-Related Macular Degeneration (AMD) AI Screening System Forecast
10.5.2 South Africa Market Age-Related Macular Degeneration (AMD) AI Screening System Forecast
10.5.3 Israel Market Age-Related Macular Degeneration (AMD) AI Screening System Forecast
10.5.4 Turkey Market Age-Related Macular Degeneration (AMD) AI Screening System Forecast
10.6 Global Age-Related Macular Degeneration (AMD) AI Screening System Forecast by Type (2025-2030)
10.7 Global Age-Related Macular Degeneration (AMD) AI Screening System Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Age-Related Macular Degeneration (AMD) AI Screening System Forecast
11 KEY PLAYERS ANALYSIS
11.1 Airdoc Technology
11.1.1 Airdoc Technology Company Information
11.1.2 Airdoc Technology Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
11.1.3 Airdoc Technology Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Airdoc Technology Main Business Overview
11.1.5 Airdoc Technology Latest Developments
11.2 Digital Diagnostics
11.2.1 Digital Diagnostics Company Information
11.2.2 Digital Diagnostics Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
11.2.3 Digital Diagnostics Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Digital Diagnostics Main Business Overview
11.2.5 Digital Diagnostics Latest Developments
11.3 Eyenuk
11.3.1 Eyenuk Company Information
11.3.2 Eyenuk Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
11.3.3 Eyenuk Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Eyenuk Main Business Overview
11.3.5 Eyenuk Latest Developments
11.4 RetinaLyze System
11.4.1 RetinaLyze System Company Information
11.4.2 RetinaLyze System Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
11.4.3 RetinaLyze System Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 RetinaLyze System Main Business Overview
11.4.5 RetinaLyze System Latest Developments
11.5 Optomed
11.5.1 Optomed Company Information
11.5.2 Optomed Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
11.5.3 Optomed Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Optomed Main Business Overview
11.5.5 Optomed Latest Developments
11.6 Sibionics Technology
11.6.1 Sibionics Technology Company Information
11.6.2 Sibionics Technology Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
11.6.3 Sibionics Technology Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Sibionics Technology Main Business Overview
11.6.5 Sibionics Technology Latest Developments
11.7 Aeye Health
11.7.1 Aeye Health Company Information
11.7.2 Aeye Health Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
11.7.3 Aeye Health Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Aeye Health Main Business Overview
11.7.5 Aeye Health Latest Developments
11.8 VUNO
11.8.1 VUNO Company Information
11.8.2 VUNO Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
11.8.3 VUNO Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 VUNO Main Business Overview
11.8.5 VUNO Latest Developments
11.9 Medimaging Integrated Solution
11.9.1 Medimaging Integrated Solution Company Information
11.9.2 Medimaging Integrated Solution Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
11.9.3 Medimaging Integrated Solution Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Medimaging Integrated Solution Main Business Overview
11.9.5 Medimaging Integrated Solution Latest Developments
11.10 EyRIS (SELENA+)
11.10.1 EyRIS (SELENA+) Company Information
11.10.2 EyRIS (SELENA+) Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
11.10.3 EyRIS (SELENA+) Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 EyRIS (SELENA+) Main Business Overview
11.10.5 EyRIS (SELENA+) Latest Developments
11.11 Vistel
11.11.1 Vistel Company Information
11.11.2 Vistel Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
11.11.3 Vistel Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Vistel Main Business Overview
11.11.5 Vistel Latest Developments
11.12 RETINA-AI Health
11.12.1 RETINA-AI Health Company Information
11.12.2 RETINA-AI Health Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
11.12.3 RETINA-AI Health Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 RETINA-AI Health Main Business Overview
11.12.5 RETINA-AI Health Latest Developments
11.13 Acer Medical
11.13.1 Acer Medical Company Information
11.13.2 Acer Medical Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
11.13.3 Acer Medical Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Acer Medical Main Business Overview
11.13.5 Acer Medical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2019-2030
2.1.2 Age-Related Macular Degeneration (AMD) AI Screening System Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Age-Related Macular Degeneration (AMD) AI Screening System by Country/Region, 2019, 2023 & 2030
2.2 Age-Related Macular Degeneration (AMD) AI Screening System Segment by Type
2.2.1 Hardware
2.2.2 Software
2.3 Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Type
2.3.1 Age-Related Macular Degeneration (AMD) AI Screening System Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Type (2019-2024)
2.4 Age-Related Macular Degeneration (AMD) AI Screening System Segment by Application
2.4.1 Medical Institutions
2.4.2 Great Health Scene
2.5 Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Application
2.5.1 Age-Related Macular Degeneration (AMD) AI Screening System Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Application (2019-2024)
3 AGE-RELATED MACULAR DEGENERATION (AMD) AI SCREENING SYSTEM MARKET SIZE BY PLAYER
3.1 Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Player
3.1.1 Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue by Player (2019-2024)
3.1.2 Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue Market Share by Player (2019-2024)
3.2 Global Age-Related Macular Degeneration (AMD) AI Screening System Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AGE-RELATED MACULAR DEGENERATION (AMD) AI SCREENING SYSTEM BY REGION
4.1 Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Region (2019-2024)
4.2 Global Age-Related Macular Degeneration (AMD) AI Screening System Annual Revenue by Country/Region (2019-2024)
4.3 Americas Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth (2019-2024)
4.4 APAC Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth (2019-2024)
4.5 Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth (2019-2024)
4.6 Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Country (2019-2024)
5.2 Americas Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Type (2019-2024)
5.3 Americas Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Region (2019-2024)
6.2 APAC Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Type (2019-2024)
6.3 APAC Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Country (2019-2024)
7.2 Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Type (2019-2024)
7.3 Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System by Region (2019-2024)
8.2 Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Type (2019-2024)
8.3 Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL AGE-RELATED MACULAR DEGENERATION (AMD) AI SCREENING SYSTEM MARKET FORECAST
10.1 Global Age-Related Macular Degeneration (AMD) AI Screening System Forecast by Region (2025-2030)
10.1.1 Global Age-Related Macular Degeneration (AMD) AI Screening System Forecast by Region (2025-2030)
10.1.2 Americas Age-Related Macular Degeneration (AMD) AI Screening System Forecast
10.1.3 APAC Age-Related Macular Degeneration (AMD) AI Screening System Forecast
10.1.4 Europe Age-Related Macular Degeneration (AMD) AI Screening System Forecast
10.1.5 Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Forecast
10.2 Americas Age-Related Macular Degeneration (AMD) AI Screening System Forecast by Country (2025-2030)
10.2.1 United States Market Age-Related Macular Degeneration (AMD) AI Screening System Forecast
10.2.2 Canada Market Age-Related Macular Degeneration (AMD) AI Screening System Forecast
10.2.3 Mexico Market Age-Related Macular Degeneration (AMD) AI Screening System Forecast
10.2.4 Brazil Market Age-Related Macular Degeneration (AMD) AI Screening System Forecast
10.3 APAC Age-Related Macular Degeneration (AMD) AI Screening System Forecast by Region (2025-2030)
10.3.1 China Age-Related Macular Degeneration (AMD) AI Screening System Market Forecast
10.3.2 Japan Market Age-Related Macular Degeneration (AMD) AI Screening System Forecast
10.3.3 Korea Market Age-Related Macular Degeneration (AMD) AI Screening System Forecast
10.3.4 Southeast Asia Market Age-Related Macular Degeneration (AMD) AI Screening System Forecast
10.3.5 India Market Age-Related Macular Degeneration (AMD) AI Screening System Forecast
10.3.6 Australia Market Age-Related Macular Degeneration (AMD) AI Screening System Forecast
10.4 Europe Age-Related Macular Degeneration (AMD) AI Screening System Forecast by Country (2025-2030)
10.4.1 Germany Market Age-Related Macular Degeneration (AMD) AI Screening System Forecast
10.4.2 France Market Age-Related Macular Degeneration (AMD) AI Screening System Forecast
10.4.3 UK Market Age-Related Macular Degeneration (AMD) AI Screening System Forecast
10.4.4 Italy Market Age-Related Macular Degeneration (AMD) AI Screening System Forecast
10.4.5 Russia Market Age-Related Macular Degeneration (AMD) AI Screening System Forecast
10.5 Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Forecast by Region (2025-2030)
10.5.1 Egypt Market Age-Related Macular Degeneration (AMD) AI Screening System Forecast
10.5.2 South Africa Market Age-Related Macular Degeneration (AMD) AI Screening System Forecast
10.5.3 Israel Market Age-Related Macular Degeneration (AMD) AI Screening System Forecast
10.5.4 Turkey Market Age-Related Macular Degeneration (AMD) AI Screening System Forecast
10.6 Global Age-Related Macular Degeneration (AMD) AI Screening System Forecast by Type (2025-2030)
10.7 Global Age-Related Macular Degeneration (AMD) AI Screening System Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Age-Related Macular Degeneration (AMD) AI Screening System Forecast
11 KEY PLAYERS ANALYSIS
11.1 Airdoc Technology
11.1.1 Airdoc Technology Company Information
11.1.2 Airdoc Technology Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
11.1.3 Airdoc Technology Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Airdoc Technology Main Business Overview
11.1.5 Airdoc Technology Latest Developments
11.2 Digital Diagnostics
11.2.1 Digital Diagnostics Company Information
11.2.2 Digital Diagnostics Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
11.2.3 Digital Diagnostics Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Digital Diagnostics Main Business Overview
11.2.5 Digital Diagnostics Latest Developments
11.3 Eyenuk
11.3.1 Eyenuk Company Information
11.3.2 Eyenuk Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
11.3.3 Eyenuk Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Eyenuk Main Business Overview
11.3.5 Eyenuk Latest Developments
11.4 RetinaLyze System
11.4.1 RetinaLyze System Company Information
11.4.2 RetinaLyze System Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
11.4.3 RetinaLyze System Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 RetinaLyze System Main Business Overview
11.4.5 RetinaLyze System Latest Developments
11.5 Optomed
11.5.1 Optomed Company Information
11.5.2 Optomed Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
11.5.3 Optomed Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Optomed Main Business Overview
11.5.5 Optomed Latest Developments
11.6 Sibionics Technology
11.6.1 Sibionics Technology Company Information
11.6.2 Sibionics Technology Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
11.6.3 Sibionics Technology Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Sibionics Technology Main Business Overview
11.6.5 Sibionics Technology Latest Developments
11.7 Aeye Health
11.7.1 Aeye Health Company Information
11.7.2 Aeye Health Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
11.7.3 Aeye Health Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Aeye Health Main Business Overview
11.7.5 Aeye Health Latest Developments
11.8 VUNO
11.8.1 VUNO Company Information
11.8.2 VUNO Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
11.8.3 VUNO Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 VUNO Main Business Overview
11.8.5 VUNO Latest Developments
11.9 Medimaging Integrated Solution
11.9.1 Medimaging Integrated Solution Company Information
11.9.2 Medimaging Integrated Solution Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
11.9.3 Medimaging Integrated Solution Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Medimaging Integrated Solution Main Business Overview
11.9.5 Medimaging Integrated Solution Latest Developments
11.10 EyRIS (SELENA+)
11.10.1 EyRIS (SELENA+) Company Information
11.10.2 EyRIS (SELENA+) Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
11.10.3 EyRIS (SELENA+) Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 EyRIS (SELENA+) Main Business Overview
11.10.5 EyRIS (SELENA+) Latest Developments
11.11 Vistel
11.11.1 Vistel Company Information
11.11.2 Vistel Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
11.11.3 Vistel Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Vistel Main Business Overview
11.11.5 Vistel Latest Developments
11.12 RETINA-AI Health
11.12.1 RETINA-AI Health Company Information
11.12.2 RETINA-AI Health Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
11.12.3 RETINA-AI Health Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 RETINA-AI Health Main Business Overview
11.12.5 RETINA-AI Health Latest Developments
11.13 Acer Medical
11.13.1 Acer Medical Company Information
11.13.2 Acer Medical Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
11.13.3 Acer Medical Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Acer Medical Main Business Overview
11.13.5 Acer Medical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Age-Related Macular Degeneration (AMD) AI Screening System Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Age-Related Macular Degeneration (AMD) AI Screening System Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Hardware
Table 4. Major Players of Software
Table 5. Age-Related Macular Degeneration (AMD) AI Screening System Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 6. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Type (2019-2024) & ($ millions)
Table 7. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Type (2019-2024)
Table 8. Age-Related Macular Degeneration (AMD) AI Screening System Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 9. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Application (2019-2024) & ($ millions)
Table 10. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Application (2019-2024)
Table 11. Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue by Player (2019-2024) & ($ millions)
Table 12. Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue Market Share by Player (2019-2024)
Table 13. Age-Related Macular Degeneration (AMD) AI Screening System Key Players Head office and Products Offered
Table 14. Age-Related Macular Degeneration (AMD) AI Screening System Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Region (2019-2024) & ($ millions)
Table 18. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Region (2019-2024)
Table 19. Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Country (2019-2024) & ($ millions)
Table 22. Americas Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Country (2019-2024)
Table 23. Americas Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Type (2019-2024) & ($ millions)
Table 24. Americas Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Type (2019-2024)
Table 25. Americas Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Application (2019-2024) & ($ millions)
Table 26. Americas Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Application (2019-2024)
Table 27. APAC Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Region (2019-2024) & ($ millions)
Table 28. APAC Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Region (2019-2024)
Table 29. APAC Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Type (2019-2024) & ($ millions)
Table 30. APAC Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Application (2019-2024) & ($ millions)
Table 31. Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Country (2019-2024) & ($ millions)
Table 32. Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Country (2019-2024)
Table 33. Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Type (2019-2024) & ($ millions)
Table 34. Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Application (2019-2024) & ($ millions)
Table 35. Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Region (2019-2024) & ($ millions)
Table 36. Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Type (2019-2024) & ($ millions)
Table 37. Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Application (2019-2024) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Age-Related Macular Degeneration (AMD) AI Screening System
Table 39. Key Market Challenges & Risks of Age-Related Macular Degeneration (AMD) AI Screening System
Table 40. Key Industry Trends of Age-Related Macular Degeneration (AMD) AI Screening System
Table 41. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Forecast by Region (2025-2030) & ($ millions)
Table 42. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share Forecast by Region (2025-2030)
Table 43. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Forecast by Type (2025-2030) & ($ millions)
Table 44. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Forecast by Application (2025-2030) & ($ millions)
Table 45. Airdoc Technology Details, Company Type, Age-Related Macular Degeneration (AMD) AI Screening System Area Served and Its Competitors
Table 46. Airdoc Technology Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
Table 47. Airdoc Technology Age-Related Macular Degeneration (AMD) AI Screening System Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 48. Airdoc Technology Main Business
Table 49. Airdoc Technology Latest Developments
Table 50. Digital Diagnostics Details, Company Type, Age-Related Macular Degeneration (AMD) AI Screening System Area Served and Its Competitors
Table 51. Digital Diagnostics Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
Table 52. Digital Diagnostics Age-Related Macular Degeneration (AMD) AI Screening System Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 53. Digital Diagnostics Main Business
Table 54. Digital Diagnostics Latest Developments
Table 55. Eyenuk Details, Company Type, Age-Related Macular Degeneration (AMD) AI Screening System Area Served and Its Competitors
Table 56. Eyenuk Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
Table 57. Eyenuk Age-Related Macular Degeneration (AMD) AI Screening System Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 58. Eyenuk Main Business
Table 59. Eyenuk Latest Developments
Table 60. RetinaLyze System Details, Company Type, Age-Related Macular Degeneration (AMD) AI Screening System Area Served and Its Competitors
Table 61. RetinaLyze System Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
Table 62. RetinaLyze System Age-Related Macular Degeneration (AMD) AI Screening System Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. RetinaLyze System Main Business
Table 64. RetinaLyze System Latest Developments
Table 65. Optomed Details, Company Type, Age-Related Macular Degeneration (AMD) AI Screening System Area Served and Its Competitors
Table 66. Optomed Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
Table 67. Optomed Age-Related Macular Degeneration (AMD) AI Screening System Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Optomed Main Business
Table 69. Optomed Latest Developments
Table 70. Sibionics Technology Details, Company Type, Age-Related Macular Degeneration (AMD) AI Screening System Area Served and Its Competitors
Table 71. Sibionics Technology Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
Table 72. Sibionics Technology Age-Related Macular Degeneration (AMD) AI Screening System Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Sibionics Technology Main Business
Table 74. Sibionics Technology Latest Developments
Table 75. Aeye Health Details, Company Type, Age-Related Macular Degeneration (AMD) AI Screening System Area Served and Its Competitors
Table 76. Aeye Health Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
Table 77. Aeye Health Age-Related Macular Degeneration (AMD) AI Screening System Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Aeye Health Main Business
Table 79. Aeye Health Latest Developments
Table 80. VUNO Details, Company Type, Age-Related Macular Degeneration (AMD) AI Screening System Area Served and Its Competitors
Table 81. VUNO Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
Table 82. VUNO Age-Related Macular Degeneration (AMD) AI Screening System Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. VUNO Main Business
Table 84. VUNO Latest Developments
Table 85. Medimaging Integrated Solution Details, Company Type, Age-Related Macular Degeneration (AMD) AI Screening System Area Served and Its Competitors
Table 86. Medimaging Integrated Solution Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
Table 87. Medimaging Integrated Solution Age-Related Macular Degeneration (AMD) AI Screening System Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Medimaging Integrated Solution Main Business
Table 89. Medimaging Integrated Solution Latest Developments
Table 90. EyRIS (SELENA+) Details, Company Type, Age-Related Macular Degeneration (AMD) AI Screening System Area Served and Its Competitors
Table 91. EyRIS (SELENA+) Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
Table 92. EyRIS (SELENA+) Age-Related Macular Degeneration (AMD) AI Screening System Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. EyRIS (SELENA+) Main Business
Table 94. EyRIS (SELENA+) Latest Developments
Table 95. Vistel Details, Company Type, Age-Related Macular Degeneration (AMD) AI Screening System Area Served and Its Competitors
Table 96. Vistel Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
Table 97. Vistel Age-Related Macular Degeneration (AMD) AI Screening System Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. Vistel Main Business
Table 99. Vistel Latest Developments
Table 100. RETINA-AI Health Details, Company Type, Age-Related Macular Degeneration (AMD) AI Screening System Area Served and Its Competitors
Table 101. RETINA-AI Health Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
Table 102. RETINA-AI Health Age-Related Macular Degeneration (AMD) AI Screening System Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 103. RETINA-AI Health Main Business
Table 104. RETINA-AI Health Latest Developments
Table 105. Acer Medical Details, Company Type, Age-Related Macular Degeneration (AMD) AI Screening System Area Served and Its Competitors
Table 106. Acer Medical Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
Table 107. Acer Medical Age-Related Macular Degeneration (AMD) AI Screening System Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 108. Acer Medical Main Business
Table 109. Acer Medical Latest Developments
Table 1. Age-Related Macular Degeneration (AMD) AI Screening System Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Age-Related Macular Degeneration (AMD) AI Screening System Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Hardware
Table 4. Major Players of Software
Table 5. Age-Related Macular Degeneration (AMD) AI Screening System Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 6. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Type (2019-2024) & ($ millions)
Table 7. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Type (2019-2024)
Table 8. Age-Related Macular Degeneration (AMD) AI Screening System Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 9. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Application (2019-2024) & ($ millions)
Table 10. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Application (2019-2024)
Table 11. Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue by Player (2019-2024) & ($ millions)
Table 12. Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue Market Share by Player (2019-2024)
Table 13. Age-Related Macular Degeneration (AMD) AI Screening System Key Players Head office and Products Offered
Table 14. Age-Related Macular Degeneration (AMD) AI Screening System Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Region (2019-2024) & ($ millions)
Table 18. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Region (2019-2024)
Table 19. Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Country (2019-2024) & ($ millions)
Table 22. Americas Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Country (2019-2024)
Table 23. Americas Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Type (2019-2024) & ($ millions)
Table 24. Americas Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Type (2019-2024)
Table 25. Americas Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Application (2019-2024) & ($ millions)
Table 26. Americas Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Application (2019-2024)
Table 27. APAC Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Region (2019-2024) & ($ millions)
Table 28. APAC Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Region (2019-2024)
Table 29. APAC Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Type (2019-2024) & ($ millions)
Table 30. APAC Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Application (2019-2024) & ($ millions)
Table 31. Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Country (2019-2024) & ($ millions)
Table 32. Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Country (2019-2024)
Table 33. Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Type (2019-2024) & ($ millions)
Table 34. Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Application (2019-2024) & ($ millions)
Table 35. Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Region (2019-2024) & ($ millions)
Table 36. Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Type (2019-2024) & ($ millions)
Table 37. Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Application (2019-2024) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Age-Related Macular Degeneration (AMD) AI Screening System
Table 39. Key Market Challenges & Risks of Age-Related Macular Degeneration (AMD) AI Screening System
Table 40. Key Industry Trends of Age-Related Macular Degeneration (AMD) AI Screening System
Table 41. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Forecast by Region (2025-2030) & ($ millions)
Table 42. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share Forecast by Region (2025-2030)
Table 43. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Forecast by Type (2025-2030) & ($ millions)
Table 44. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Forecast by Application (2025-2030) & ($ millions)
Table 45. Airdoc Technology Details, Company Type, Age-Related Macular Degeneration (AMD) AI Screening System Area Served and Its Competitors
Table 46. Airdoc Technology Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
Table 47. Airdoc Technology Age-Related Macular Degeneration (AMD) AI Screening System Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 48. Airdoc Technology Main Business
Table 49. Airdoc Technology Latest Developments
Table 50. Digital Diagnostics Details, Company Type, Age-Related Macular Degeneration (AMD) AI Screening System Area Served and Its Competitors
Table 51. Digital Diagnostics Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
Table 52. Digital Diagnostics Age-Related Macular Degeneration (AMD) AI Screening System Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 53. Digital Diagnostics Main Business
Table 54. Digital Diagnostics Latest Developments
Table 55. Eyenuk Details, Company Type, Age-Related Macular Degeneration (AMD) AI Screening System Area Served and Its Competitors
Table 56. Eyenuk Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
Table 57. Eyenuk Age-Related Macular Degeneration (AMD) AI Screening System Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 58. Eyenuk Main Business
Table 59. Eyenuk Latest Developments
Table 60. RetinaLyze System Details, Company Type, Age-Related Macular Degeneration (AMD) AI Screening System Area Served and Its Competitors
Table 61. RetinaLyze System Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
Table 62. RetinaLyze System Age-Related Macular Degeneration (AMD) AI Screening System Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. RetinaLyze System Main Business
Table 64. RetinaLyze System Latest Developments
Table 65. Optomed Details, Company Type, Age-Related Macular Degeneration (AMD) AI Screening System Area Served and Its Competitors
Table 66. Optomed Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
Table 67. Optomed Age-Related Macular Degeneration (AMD) AI Screening System Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Optomed Main Business
Table 69. Optomed Latest Developments
Table 70. Sibionics Technology Details, Company Type, Age-Related Macular Degeneration (AMD) AI Screening System Area Served and Its Competitors
Table 71. Sibionics Technology Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
Table 72. Sibionics Technology Age-Related Macular Degeneration (AMD) AI Screening System Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Sibionics Technology Main Business
Table 74. Sibionics Technology Latest Developments
Table 75. Aeye Health Details, Company Type, Age-Related Macular Degeneration (AMD) AI Screening System Area Served and Its Competitors
Table 76. Aeye Health Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
Table 77. Aeye Health Age-Related Macular Degeneration (AMD) AI Screening System Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Aeye Health Main Business
Table 79. Aeye Health Latest Developments
Table 80. VUNO Details, Company Type, Age-Related Macular Degeneration (AMD) AI Screening System Area Served and Its Competitors
Table 81. VUNO Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
Table 82. VUNO Age-Related Macular Degeneration (AMD) AI Screening System Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. VUNO Main Business
Table 84. VUNO Latest Developments
Table 85. Medimaging Integrated Solution Details, Company Type, Age-Related Macular Degeneration (AMD) AI Screening System Area Served and Its Competitors
Table 86. Medimaging Integrated Solution Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
Table 87. Medimaging Integrated Solution Age-Related Macular Degeneration (AMD) AI Screening System Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Medimaging Integrated Solution Main Business
Table 89. Medimaging Integrated Solution Latest Developments
Table 90. EyRIS (SELENA+) Details, Company Type, Age-Related Macular Degeneration (AMD) AI Screening System Area Served and Its Competitors
Table 91. EyRIS (SELENA+) Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
Table 92. EyRIS (SELENA+) Age-Related Macular Degeneration (AMD) AI Screening System Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. EyRIS (SELENA+) Main Business
Table 94. EyRIS (SELENA+) Latest Developments
Table 95. Vistel Details, Company Type, Age-Related Macular Degeneration (AMD) AI Screening System Area Served and Its Competitors
Table 96. Vistel Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
Table 97. Vistel Age-Related Macular Degeneration (AMD) AI Screening System Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. Vistel Main Business
Table 99. Vistel Latest Developments
Table 100. RETINA-AI Health Details, Company Type, Age-Related Macular Degeneration (AMD) AI Screening System Area Served and Its Competitors
Table 101. RETINA-AI Health Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
Table 102. RETINA-AI Health Age-Related Macular Degeneration (AMD) AI Screening System Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 103. RETINA-AI Health Main Business
Table 104. RETINA-AI Health Latest Developments
Table 105. Acer Medical Details, Company Type, Age-Related Macular Degeneration (AMD) AI Screening System Area Served and Its Competitors
Table 106. Acer Medical Age-Related Macular Degeneration (AMD) AI Screening System Product Offered
Table 107. Acer Medical Age-Related Macular Degeneration (AMD) AI Screening System Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 108. Acer Medical Main Business
Table 109. Acer Medical Latest Developments
LIST OF FIGURES
Figure 1. Age-Related Macular Degeneration (AMD) AI Screening System Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Age-Related Macular Degeneration (AMD) AI Screening System Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Age-Related Macular Degeneration (AMD) AI Screening System Sales Market Share by Country/Region (2023)
Figure 8. Age-Related Macular Degeneration (AMD) AI Screening System Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Type in 2023
Figure 10. Age-Related Macular Degeneration (AMD) AI Screening System in Medical Institutions
Figure 11. Global Age-Related Macular Degeneration (AMD) AI Screening System Market: Medical Institutions (2019-2024) & ($ millions)
Figure 12. Age-Related Macular Degeneration (AMD) AI Screening System in Great Health Scene
Figure 13. Global Age-Related Macular Degeneration (AMD) AI Screening System Market: Great Health Scene (2019-2024) & ($ millions)
Figure 14. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Application in 2023
Figure 15. Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue Market Share by Player in 2023
Figure 16. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Region (2019-2024)
Figure 17. Americas Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2019-2024 ($ millions)
Figure 18. APAC Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2019-2024 ($ millions)
Figure 19. Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2019-2024 ($ millions)
Figure 20. Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2019-2024 ($ millions)
Figure 21. Americas Age-Related Macular Degeneration (AMD) AI Screening System Value Market Share by Country in 2023
Figure 22. United States Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth 2019-2024 ($ millions)
Figure 23. Canada Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth 2019-2024 ($ millions)
Figure 24. Mexico Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth 2019-2024 ($ millions)
Figure 25. Brazil Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth 2019-2024 ($ millions)
Figure 26. APAC Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Region in 2023
Figure 27. APAC Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Type (2019-2024)
Figure 28. APAC Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Application (2019-2024)
Figure 29. China Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth 2019-2024 ($ millions)
Figure 30. Japan Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth 2019-2024 ($ millions)
Figure 31. South Korea Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth 2019-2024 ($ millions)
Figure 32. Southeast Asia Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth 2019-2024 ($ millions)
Figure 33. India Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth 2019-2024 ($ millions)
Figure 34. Australia Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth 2019-2024 ($ millions)
Figure 35. Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Country in 2023
Figure 36. Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Type (2019-2024)
Figure 37. Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Application (2019-2024)
Figure 38. Germany Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth 2019-2024 ($ millions)
Figure 39. France Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth 2019-2024 ($ millions)
Figure 40. UK Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth 2019-2024 ($ millions)
Figure 41. Italy Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth 2019-2024 ($ millions)
Figure 42. Russia Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth 2019-2024 ($ millions)
Figure 43. Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth 2019-2024 ($ millions)
Figure 47. South Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth 2019-2024 ($ millions)
Figure 48. Israel Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth 2019-2024 ($ millions)
Figure 49. Turkey Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth 2019-2024 ($ millions)
Figure 50. GCC Countries Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth 2019-2024 ($ millions)
Figure 51. Americas Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 52. APAC Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 53. Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 54. Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 55. United States Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 56. Canada Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 57. Mexico Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 58. Brazil Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 59. China Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 60. Japan Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 61. Korea Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 62. Southeast Asia Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 63. India Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 64. Australia Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 65. Germany Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 66. France Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 67. UK Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 68. Italy Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 69. Russia Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 70. Egypt Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 71. South Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 72. Israel Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 73. Turkey Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 74. GCC Countries Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 75. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share Forecast by Type (2025-2030)
Figure 76. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Age-Related Macular Degeneration (AMD) AI Screening System Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Age-Related Macular Degeneration (AMD) AI Screening System Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Age-Related Macular Degeneration (AMD) AI Screening System Sales Market Share by Country/Region (2023)
Figure 8. Age-Related Macular Degeneration (AMD) AI Screening System Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Type in 2023
Figure 10. Age-Related Macular Degeneration (AMD) AI Screening System in Medical Institutions
Figure 11. Global Age-Related Macular Degeneration (AMD) AI Screening System Market: Medical Institutions (2019-2024) & ($ millions)
Figure 12. Age-Related Macular Degeneration (AMD) AI Screening System in Great Health Scene
Figure 13. Global Age-Related Macular Degeneration (AMD) AI Screening System Market: Great Health Scene (2019-2024) & ($ millions)
Figure 14. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Application in 2023
Figure 15. Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue Market Share by Player in 2023
Figure 16. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Region (2019-2024)
Figure 17. Americas Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2019-2024 ($ millions)
Figure 18. APAC Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2019-2024 ($ millions)
Figure 19. Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2019-2024 ($ millions)
Figure 20. Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2019-2024 ($ millions)
Figure 21. Americas Age-Related Macular Degeneration (AMD) AI Screening System Value Market Share by Country in 2023
Figure 22. United States Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth 2019-2024 ($ millions)
Figure 23. Canada Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth 2019-2024 ($ millions)
Figure 24. Mexico Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth 2019-2024 ($ millions)
Figure 25. Brazil Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth 2019-2024 ($ millions)
Figure 26. APAC Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Region in 2023
Figure 27. APAC Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Type (2019-2024)
Figure 28. APAC Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Application (2019-2024)
Figure 29. China Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth 2019-2024 ($ millions)
Figure 30. Japan Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth 2019-2024 ($ millions)
Figure 31. South Korea Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth 2019-2024 ($ millions)
Figure 32. Southeast Asia Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth 2019-2024 ($ millions)
Figure 33. India Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth 2019-2024 ($ millions)
Figure 34. Australia Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth 2019-2024 ($ millions)
Figure 35. Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Country in 2023
Figure 36. Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Type (2019-2024)
Figure 37. Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Application (2019-2024)
Figure 38. Germany Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth 2019-2024 ($ millions)
Figure 39. France Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth 2019-2024 ($ millions)
Figure 40. UK Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth 2019-2024 ($ millions)
Figure 41. Italy Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth 2019-2024 ($ millions)
Figure 42. Russia Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth 2019-2024 ($ millions)
Figure 43. Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth 2019-2024 ($ millions)
Figure 47. South Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth 2019-2024 ($ millions)
Figure 48. Israel Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth 2019-2024 ($ millions)
Figure 49. Turkey Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth 2019-2024 ($ millions)
Figure 50. GCC Countries Age-Related Macular Degeneration (AMD) AI Screening System Market Size Growth 2019-2024 ($ millions)
Figure 51. Americas Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 52. APAC Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 53. Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 54. Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 55. United States Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 56. Canada Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 57. Mexico Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 58. Brazil Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 59. China Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 60. Japan Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 61. Korea Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 62. Southeast Asia Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 63. India Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 64. Australia Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 65. Germany Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 66. France Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 67. UK Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 68. Italy Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 69. Russia Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 70. Egypt Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 71. South Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 72. Israel Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 73. Turkey Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 74. GCC Countries Age-Related Macular Degeneration (AMD) AI Screening System Market Size 2025-2030 ($ millions)
Figure 75. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share Forecast by Type (2025-2030)
Figure 76. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size Market Share Forecast by Application (2025-2030)
